BIG
TGTX icon

Brookwood Investment Group’s TG Therapeutics TGTX Stock Holding History

Brookwood Investment Group’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$325K Buy
+5,910
New +$242K 0.04% 387
2025
Q4 		– Sell
-5,910
Closed -$213K – 569
2025
Q3 		$213K Hold
5,910
– – 0.03% 446
2025
Q2 		$213K Sell
5,910
-14
-0.2% -$521 0.03% 405
2025
Q1 		$234K Buy
+5,924
New +$199K 0.04% 359

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Brookwood Investment Group's TGTX Position: Q2 2026 in Review

Brookwood Investment Group opened a new position in TG Therapeutics (TGTX) in Q2 2026: 5,910 shares worth $325K. The stake represents 0.04% of the portfolio and ranks #387 among its holdings. This is a return to the name: Brookwood Investment Group previously reported a position in TGTX as recently as Q3 2025.

Brookwood Investment Group first reported a position in TGTX in Q1 2025 and has held it in 4 quarters since. 427 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Brookwood Investment Group held 5,910 shares of TG Therapeutics worth $325K as of Q2 2026.
  • TG Therapeutics was a new Brookwood Investment Group position in Q2 2026.
  • TG Therapeutics made up 0.04% of Brookwood Investment Group's portfolio in Q2 2026, its #387 holding.
  • Brookwood Investment Group first reported a position in TG Therapeutics in Q1 2025 and has held it in 4 quarters since.
  • 427 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Brookwood Investment Group's 13F filing for Q2 2026, filed 23 Jul 2026.